Tandem Diabetes Care (TNDM) Total Liabilities (2013 - 2026)

Tandem Diabetes Care (TNDM) has reported Total Liabilities for 14 consecutive years, with $1.0 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Liabilities rose 37.9% year-over-year to $1.0 billion; the trailing twelve-month figure through Jun 2026 stood at $1.0 billion (up 37.9% YoY), and the FY2025 full-year result was $725.9 million, up 3.03% from the prior year.
• Total Liabilities held at $1.0 billion in Q2 2026 per TNDM's latest filing, from $1.0 billion in the prior quarter.
• Across five years, Total Liabilities topped out at $1.0 billion in Q2 2026 and bottomed at $577.9 million in Q1 2022.
• Historically, Total Liabilities has averaged $708.3 million across 5 years, with a median of $700.8 million in 2024.
• The sharpest annual moves came in 2023 and 2026: Total Liabilities increased 0.03% in 2023, then soared 37.9% in 2026.
• Over 5 years, Total Liabilities stood at $612.8 million in 2022, then climbed by 4.27% to $639.0 million in 2023, then grew by 10.26% to $704.6 million in 2024, then rose by 3.03% to $725.9 million in 2025, then jumped by 41.03% to $1.0 billion in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $1.0 billion, $1.0 billion, and $725.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.